Molecular Partners Ag (MOLN) Equity Average (2021 - 2025)
Historic Equity Average for Molecular Partners Ag (MOLN) over the last 4 years, with Q3 2025 value amounting to $124127.2.
- Molecular Partners Ag's Equity Average fell 9985.58% to $124127.2 in Q3 2025 from the same period last year, while for Sep 2025 it was $124127.2, marking a year-over-year decrease of 9985.58%. This contributed to the annual value of $179947.9 for FY2024, which is 1876.04% down from last year.
- Molecular Partners Ag's Equity Average amounted to $124127.2 in Q3 2025, which was down 9985.58% from $135709.4 recorded in Q2 2025.
- In the past 5 years, Molecular Partners Ag's Equity Average registered a high of $138.2 million during Q2 2022, and its lowest value of $124127.2 during Q3 2025.
- Over the past 4 years, Molecular Partners Ag's median Equity Average value was $242150.9 (recorded in 2023), while the average stood at $45.3 million.
- As far as peak fluctuations go, Molecular Partners Ag's Equity Average skyrocketed by 2024.73% in 2023, and later plummeted by 9985.58% in 2025.
- Over the past 4 years, Molecular Partners Ag's Equity Average (Quarter) stood at $252228.2 in 2022, then decreased by 16.54% to $210518.3 in 2023, then dropped by 23.56% to $160929.6 in 2024, then decreased by 22.87% to $124127.2 in 2025.
- Its Equity Average was $124127.2 in Q3 2025, compared to $135709.4 in Q2 2025 and $152131.7 in Q1 2025.